fda fast track - Robuta Search

https://www.prnewswire.com/news-releases/expression-therapeutics-receives-fda-fast-track-and-rare-pediatric-disease-designations-for-investigational-stem-cell-therapy-for-hemophilia-a-302756492.html Expression Therapeutics Receives FDA Fast Track and Rare Pediatric Disease Designations for... /PRNewswire/ -- Expression Therapeutics, Inc., a clinical-stage biopharmaceutical company developing a curative autologous stem cell therapy for hemophilia... fda fast track https://www.globenewswire.com/news-release/2026/04/07/3268966/0/en/Climb-Bio-Announces-FDA-Fast-Track-Designation-for-Budoprutug-for-the-Treatment-of-Primary-Membranous-Nephropathy.html?_gl=1*4pljp4*_up*MQ..*_ga*MjAzNzAxNzQ4My4xNzc1NjA0MDg0*_ga_B6167QB2TF*czE3NzU2MDQwODMkbzEkZzAkdDE3NzU2MDQwODMkajYwJGwwJGgw*_ga_ERWPGTJ5X8*czE3NzU2MDQwODMkbzEkZzAkdDE3NzU2MDQwODMkajYwJGwwJGgw Climb Bio Announces FDA Fast Track Designation for Global Phase 2 open-label clinical trial in pMN (PrisMN) enrolling, with initial data anticipated H2 2026... fda fast track climb bio announces designation https://www.businesswire.com/news/home/20250107433815/en/Vergent-Bioscience-Receives-FDA-Fast-Track-Designation-for-Abenacianine-for-Injection-VGT-309-to-Help-Surgeons-Visualize-Tumors-in-the-Lung-During-Surgery Vergent Bioscience Receives FDA Fast Track Designation for Abenacianine for Injection (VGT-309) to... fda fast track https://www.biospace.com/sierra-announces-momelotinib-granted-fda-fast-track-designation Sierra Announces Momelotinib Granted FDA Fast Track Designation - BioSpace Jun 6, 2019 - Sierra Oncology, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to momelotinib, a JAK1, JAK2 and ACVR1... fda fast track sierra announces momelotinib granted https://www.globenewswire.com/news-release/2025/04/29/3070088/0/en/incyclix-bio-granted-u-s-fda-fast-track-designation-for-inx-315-to-treat-ccne1-amplified-platinum-resistant-refractory-ovarian-cancer.html Incyclix Bio Granted U.S. FDA Fast Track Designation for Fast Track designation highlights potential of INX-315 to address unmet need for patients with recurrent advanced/metastatic cancer... u s fda fast track designation bio granted https://www.sanofi.com/en/media-room/press-releases/2020/2020-11-18-06-15-00-2128828 Press Release: Rilzabrutinib granted FDA Fast Track Designation for treatment of immune... Rilzabrutinib granted FDA Fast Track... fda fast track press release https://fdafasttrack.com/ FDA Fast Track Institute | ARCS Scientific AI Accelerate 510(k), PMA, and De Novo submissions by 60% using ARCS Scientific AI. 89% first-pass FDA acceptance rates. fda fast track institute arcs scientific ai https://www.globenewswire.com/news-release/2025/06/17/3101007/0/en/BioAegis-Therapeutics-Receives-FDA-Fast-Track-Designation-for-Lead-Product-Recombinant-Human-Gelsolin-for-the-Treatment-of-Acute-Respiratory-Distress-Syndrome-ARDS.html BioAegis Therapeutics Receives FDA Fast Track Designation Fast Track status enables expedited regulatory review timelines and supports the development of recombinant human plasma gelsolin (rhu-pGSN), a novel... fda fast track therapeutics receives designation https://www.biospace.com/logicbio-therapeutics-receives-fda-fast-track-designation-for-lb-001-for-the-treatment-of-methylmalonic-acidemia-mma LogicBio Therapeutics Receives FDA Fast Track Designation for LB-001 for the Treatment of... Nov 4, 2020 - LogicBio Therapeutics, Inc. (Nasdaq:LOGC) (LogicBio), a company dedicated to extending the reach of genetic medicine with pioneering targeted delivery... fda fast track https://www.prnewswire.com/news-releases/oncusp-therapeutics-receives-fda-fast-track-designation-for-cusp06-for-the-treatment-of-platinum-resistant-ovarian-cancer-302374728.html OnCusp Therapeutics Receives FDA Fast Track Designation for CUSP06 for the Treatment of... /PRNewswire/ -- OnCusp Therapeutics, Inc., a clinical stage biopharmaceutical company dedicated to transforming cutting-edge preclinical innovation into... fda fast track https://www.prnewswire.com/news-releases/shires-shp626-volixibat-receives-fda-fast-track-designation-for-an-investigational-treatment-for-adults-who-have-nonalcoholic-steatohepatitis-nash-with-liver-fibrosis-588636781.html Shire's SHP626 (Volixibat) Receives FDA Fast Track Designation for an Investigational Treatment for... /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) today announced that the United States Food and Drug Administration (FDA) has granted Fast Track... fda fast track https://finviz.com/news/118578/calidi-biotherapeutics-receives-fda-fast-track-designation-for-cld-201-supernova-a-first-in-class-stem-cell-loaded-viral-therapy-for-the-treatment-of-patients-with-soft-tissue-sarcoma Calidi Biotherapeutics Receives FDA Fast Track Designation for CLD-201 (SuperNova), a... Stock screener for investors and traders, financial visualizations. fda fast track https://www.finanznachrichten.de/nachrichten-2026-04/68181011-kymera-therapeutics-inc-kymera-therapeutics-announces-u-s-fda-fast-track-designation-for-kt-621-a-first-in-class-oral-stat6-degrader-for-the-tre-399.htm Kymera Therapeutics, Inc.: Kymera Therapeutics Announces U.S. FDA Fast Track Designation for... KT-621 BREADTH Phase 2b asthma trial ongoing, with data expected to be reported in late 2027 KT-621 BROADEN2 Phase 2b atopic dermatitis (AD) trial ongoing,... u s fda fast track designation kymera therapeutics inc https://www.globenewswire.com/de/news-release/2025/04/29/3070088/0/en/incyclix-bio-granted-u-s-fda-fast-track-designation-for-inx-315-to-treat-ccne1-amplified-platinum-resistant-refractory-ovarian-cancer.html Incyclix Bio Granted U.S. FDA Fast Track Designation for Fast Track designation highlights potential of INX-315 to address unmet need for patients with recurrent advanced/metastatic cancer... u s fda fast track designation bio granted https://investingnews.com/daily/life-science-investing/biotech-investing/calithera-biosciences-announces-fda-fast-track-designation-granted-cb-839/ Calithera Biosciences Announces FDA Fast Track Designation Granted to CB-839 | INN Jan 5, 2026 - Calithera Biosciences (Nasdaq:CALA), a clinical stage biotechnology company focused on the development of novel cancer therapeutics, today announced that the... fda fast track https://www.prnewswire.com/il/news-releases/spinogenix-receives-us-fda-fast-track-designation-for-tazbentetol-for-the-treatment-of-als-302762461.html Spinogenix Receives U.S. FDA Fast Track Designation for Tazbentetol for the Treatment of ALS /PRNewswire/ -- Spinogenix, Inc., a clinical-stage biopharmaceutical company pioneering novel therapeutics that have the potential to restore synapses to... https://finviz.com/news/254966/palvella-therapeutics-granted-fda-fast-track-designation-for-qtorin-39-rapamycin-anhydrous-gel-qtorin-rapamycin-for-the-treatment-of-angiokeratomas Palvella Therapeutics Granted FDA Fast Track Designation for QTORIN 3.9% Rapamycin Anhydrous Gel... Stock screener for investors and traders, financial visualizations.